US 11,806,494 B2
Systems and methods for the treatment of pelvic disorders including magnetic particulates
Natalie Ann Borgos, Lino Lakes, MN (US); Tania M. Schroeder, Hastings, MN (US); David J. Yonce, Fridley, MN (US); Robert E. Lund, Saint Michael, MN (US); and Suranajan Roychowdhury, Plymouth, MN (US)
Assigned to Boston Scientific Scimed, Inc., Maple Grove, MN (US)
Filed by Boston Scientific Scimed, Inc., Maple Grove, MN (US)
Filed on Apr. 15, 2021, as Appl. No. 17/301,831.
Application 17/301,831 is a continuation of application No. 16/103,390, filed on Aug. 14, 2018, granted, now 11,007,357.
Application 16/103,390 is a continuation of application No. 15/613,664, filed on Jun. 5, 2017, granted, now 10,076,647, issued on Sep. 18, 2018.
Application 15/613,664 is a continuation of application No. 13/205,039, filed on Aug. 8, 2011, granted, now 9,669,200, issued on Jun. 6, 2017.
Claims priority of provisional application 61/371,609, filed on Aug. 6, 2010.
Claims priority of provisional application 61/371,232, filed on Aug. 6, 2010.
Prior Publication US 2021/0299421 A1, Sep. 30, 2021
Int. Cl. A61F 5/41 (2006.01); A61M 35/00 (2006.01)
CPC A61M 35/003 (2013.01) [A61F 5/41 (2013.01); A61F 2005/411 (2013.01); A61F 2005/418 (2013.01)] 11 Claims
OG exemplary drawing
 
1. A system for the treatment of a pelvic disorder comprising:
(a) a composition comprising magnetic particulates which are either (i) physically associated with a cell population (ii) or physically associated with a drug or a biologic agent, or both (i) and (ii), which are configured for injection into a pelvic tissue; and
(b) a device configured to be associated with a pelvic anatomical structure, the device having a platform pivotally coupled to a roller and being capable of providing a magnetic field which influences movement of the magnetic particulates and associated cell population, drug, or biologic agent within the pelvic tissue.